Anderman Jonathan

General CounselCompass Therapeutics, Inc. (CMPX) · full profile →Form 4/A · filed Apr 30, 2026
Net Buying
Open-Market Buys
$47K
Open-Market Sells
$0
Net Open-Market Flow
$47K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2026Buy(P)25K$1.89$47K196K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001171843-26-002893) within minutes of acceptance. Every field above traces to the original document. Verify it directly: